Skip to main content
University of Wisconsin–Madison
UW Crest
Ophthalmology and Visual Sciences
  • Home
  • About Us Expand Collapse
    • About Us
    • Alumni
    • Annual Report / Newsletter
    • Careers
    • Directory
    • Giving
    • Leadership
  • Education Expand Collapse
    • Clinical Fellowships
    • Global Ophthalmology
    • Orthoptist Training Program
    • Pre-Residency Fellowships
    • Residency Program
    • Vision Research Opportunities
    • Vision Research Training Program
    • Visiting Medical Students
  • Research Expand Collapse
    • A-EYE Research Unit
    • Clinical Eye Research Unit
    • Laboratories
    • Publications
    • Research Resources
    • Vision Research Core
    • Vision Research Training Program
    • WAIVS
    • Wisconsin Reading Center
  • Global Ophthalmology
  • Careers
  • People First
  • Events
  • Giving
  • News

Publications

Association mapping of the high-grade myopia MYP3 locus reveals novel candidates UHRF1BP1L, PTPRR, and PPFIA2.

Posted on March 21, 2013

PubMed ID: 23422819 Author(s): Hawthorne F, Feng S, Metlapally R, Li YJ, Tran-Viet KN, Guggenheim JA, Malecaze F, Calvas P, Rosenberg T, Mackey DA, Venturini C, Hysi PG, Hammond CJ, Young TL. Association mapping of …

Posted in Publications, Young Lab

Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways.

Posted on March 15, 2013

PubMed ID: 23418351 Author(s): Park S, Dimaio TA, Liu W, Wang S, Sorenson CM, Sheibani N. Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways. J Cell …

Posted in Publications, Sheibani Lab

The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies.

Posted on March 11, 2013

PubMed ID: 23404115 Author(s): Sheetz MJ, Aiello LP, Davis MD, Danis R, Bek T, Cunha-Vaz J, Shahri N, Berg PH; MBDL and MBCU Study Groups. The effect of the oral PKC β inhibitor ruboxistaurin on …

Posted in Matthew Davis, Publications

Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis.

Posted on March 11, 2013

PubMed ID: 23422829 Author(s): Janssen KT, Mac Nair CE, Dietz JA, Schlamp CL, Nickells RW. Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis. Invest Ophthalmol Vis Sci. 2013 Mar 11;54(3):1805-15. doi: …

Posted in Nickells Lab, Publications

High glucose and diabetes modulate cellular proteasome function: Implications in the pathogenesis of diabetes complications.

Posted on March 8, 2013

PubMed ID: 23391566 Author(s): Aghdam SY, Gurel Z, Ghaffarieh A, Sorenson CM, Sheibani N. High glucose and diabetes modulate cellular proteasome function: Implications in the pathogenesis of diabetes complications. Biochem Biophys Res Commun. 2013 Mar …

Posted in Publications, Sheibani Lab

Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death.

Posted on March 5, 2013

PubMed ID: 23431148 Author(s): Welsbie DS, Yang Z, Ge Y, Mitchell KL, Zhou X, Martin SE, Berlinicke CA, Hackler L Jr, Fuller J, Fu J, Cao LH, Han B, Auld D, Xue T, Hirai S, …

Posted in Nickells Lab, Publications

Eye bank tissue utilization between endothelial keratoplasty and penetrating keratoplasty.

Posted on March 1, 2013

PubMed ID: 22820607 Author(s): Croasdale CR, Barney E, Warner EJ. Eye bank tissue utilization between endothelial keratoplasty and penetrating keratoplasty. Cornea. 2013 Mar;32(3):280-4. doi: 10.1097/ICO.0b013e3182561305. PMID 22820607 Journal: Cornea, Volume 32, Issue 3, Mar 2013 …

Posted in Evan Warner, Publications

CYP1B1, MYOC, and LTBP2 mutations in primary congenital glaucoma patients in the United States.

Posted on March 1, 2013

PubMed ID: 23218701 Author(s): Lim SH, Tran-Viet KN, Yanovitch TL, Freedman SF, Klemm T, Call W, Powell C, Ravichandran A, Metlapally R, Nading EB, Rozen S, Young TL. CYP1B1, MYOC, and LTBP2 mutations in primary …

Posted in Publications, Young Lab

Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism.

Posted on March 1, 2013

PubMed ID: 23303344 Author(s): Lavine JA, Sang Y, Wang S, Ip MS, Sheibani N. Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism. JAMA Ophthalmol. 2013 Mar;131(3):376-82. doi: 10.1001/jamaophthalmol.2013.1476. PMID 23303344 Journal: Jama Ophthalmology, Volume 131, Issue …

Posted in Michael Ip, Publications, Sheibani Lab
  • Previous page
  • 1
  • 218
  • 219
  • You're on page 220
  • 221
  • 222
  • 618
  • Next page

Site footer content



University logo that links to main university website


Quick Links

  • News
  • Contact Us
  • Giving
  • Intranet Login
  • UW-Madison School of Medicine and Public Health

Contact Us

  • 2828 Marshall Court
    Madison, WI 53705
    • facebook
    • instagram
    • linkedin

Website feedback, questions or accessibility issues: webmaster@ophth.wisc.edu.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.